MMedication Read More New studies reveal rare but real risk of GLP-1 drugsJuly 25, 2026 July 22 (Reuters) – The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes,…
MMedication Read More FDA peptide votes could open the door to more unproven drugs: ‘Pandora’s box’July 24, 2026 A Food and Drug Administration advisory committee on Friday recommended allowing two more unproven peptides to be compounded,…
MMedication Read More Lilly to file for next-gen obesity drug approval in early 2027July 24, 2026 Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
MMedication Read More The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patientsJuly 24, 2026 GLP-1 medications have been shown to improve health and offer strong value for their price, yet many insurance…
MMedication Read More Can Ozempic rewire the addicted brain? : NPRJuly 24, 2026 Part 1 of the TED Radio Hour episode Rethinking addiction in the age of Ozempic GLP-1s revolutionized weight-loss and diabetes…
MMedication Read More Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills | Local NewsJuly 24, 2026 LOUISVILLE, Ky. (WDRB/Gray Media) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another…
MMedication Read More Doctors are using a regulatory gap to prescribe an unauthorized peptideJuly 24, 2026 Despite Health Canada’s warnings against the use of unauthorized peptides as a health and fitness shortcut, a CBC…
MMedication Read More Pharmalittle: FDA panel backs pharmacies to make peptidesJuly 24, 2026 And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
MMedication Read More Health news round-up: coffee, ADHD prescribing, and GLP-1s and hair lossJuly 24, 2026 The first cohort of MPharm pharmacist prescribers received their General Pharmaceutical Council (GPhC) registration results this week, with…
MMedication Read More Australian regulator warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic | HealthJuly 24, 2026 Australia’s medicines regulator has issued warnings for several type 2 diabetes and obesity-related treatments – including Ozempic and…
MMedication Read More The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patientsJuly 24, 2026 GLP-1 medications have been shown to improve health and offer strong value for their price, yet many insurance…
MMedication Read More Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pillsJuly 24, 2026 (Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…